Biosurfit

How a real problem became an everyday solution

Big Idea

Based on proprietary technology, its lead product, spinit®, commercially launched in 2014, is the first and only diagnostics system capable of performing the major Point-of-Care blood test modalities (haematology, immunology and clinical chemistry) using the same instrument. spinit® addresses an unmet need for fast, precise, reliable, easy-to-use blood analysis for medical testing in the point-of-care setting.

Year Invested

2005

Sector

Healthcare & Life Sciences

Stage

Commercial

Team

João Garcia da Fonseca – CEO; Ian Gilham – Chairman; Daniel Neves – CMO; Nuno Reis – Senior R&D Manager.

Portugal Ventures Investment Manager

Nuno Macedo